Scemblix side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Scemblix (asciminib hydrochloride). Common side effects include death among females and death among males.
The phase IV clinical study is created by eHealthMe based on 948 reports from the FDA, and is updated regularly.
What is Scemblix?
Scemblix has active ingredients of asciminib hydrochloride. eHealthMe is studying from 948 Scemblix users. Check the latest studies of Scemblix.
948 people who take Scemblix and have side effects are studied.

What are the common side effects of Scemblix, by gender? *
What are the common side effects of Scemblix, by age (0-1 to 60+)? *
What are the common side effects of Scemblix, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Scemblix?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on asciminib hydrochloride (the active ingredients of Scemblix) and Scemblix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Scemblix:
- Scemblix (948 reports)
All Scemblix side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Milk Thistle cause Ligament Sprain? - 16 seconds ago
- Vision Blurred in Montelukast Sodium, how severe and when it was recovered? - 17 seconds ago
- Ranitidine and Nephrogenic Anaemia for Men aged 50-59 - 18 seconds ago
- Mouth Ulcers and drugs of ingredients of levetiracetam - 30 seconds ago
- Doxycycline Hyclate and Azithromycin drug interactions for men aged 50-59 - 32 seconds ago
- Carboplatin and Advair Diskus 100/50 drug interactions for women aged 30-39 - 37 seconds ago
- Attention Deficit Hyperactivity Disorder and drugs of ingredients of midazolam hydrochloride - 39 seconds ago
- Attention Deficit/Hyperactivity Disorder and drugs of ingredients of midazolam hydrochloride - 39 seconds ago
- Flector vs. Endep, side effect and effectiveness comparison - 39 seconds ago
- Joint Pain and drugs of ingredients of trametinib dimethyl sulfoxide - 41 seconds ago